Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Antibody targeting of E3 ubiquitin ligases for receptor degradation.
Nature. 2022 Oct;610(7930):182-189. doi: 10.1038/s41586-022-05235-6. Epub 2022 Sep 21.
Nature. 2022.
PMID: 36131013
Free PMC article.
Disruption of stem cell niche-confined R-spondin 3 expression leads to impaired hematopoiesis.
Kurtova AV, Heinlein M, Haas S, Velten L, Dijkgraaf GJP, Storm EE, Kljavin NM, Boumahdi S, Himmels P, Herault A, Mancini A, Koeppen H, Dail M, Yan Q, Zhang J, Koch U, Radtke F, Modrusan Z, Metcalfe C, Piskol R, de Sauvage FJ.
Kurtova AV, et al.
Blood Adv. 2023 Feb 28;7(4):491-507. doi: 10.1182/bloodadvances.2022007714.
Blood Adv. 2023.
PMID: 35914228
Free PMC article.
Item in Clipboard
ORAOV1, CCND1, and MIR548K Are the Driver Oncogenes of the 11q13 Amplicon in Squamous Cell Carcinoma.
Mahieu CI, Mancini AG, Vikram EP, Planells-Palop V, Joseph NM, Tward AD.
Mahieu CI, et al. Among authors: mancini ag.
Mol Cancer Res. 2024 Feb 1;22(2):152-168. doi: 10.1158/1541-7786.MCR-23-0746.
Mol Cancer Res. 2024.
PMID: 37930255
Free PMC article.
Item in Clipboard
Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing.
Balke-Want H, Keerthi V, Gkitsas N, Mancini AG, Kurgan GL, Fowler C, Xu P, Liu X, Asano K, Patel S, Fisher CJ, Brown AK, Tunuguntla RH, Patel S, Sotillo E, Mackall CL, Feldman SA.
Balke-Want H, et al. Among authors: mancini ag.
Mol Cancer. 2023 Jun 26;22(1):100. doi: 10.1186/s12943-023-01799-7.
Mol Cancer. 2023.
PMID: 37365642
Free PMC article.
Item in Clipboard
Cite
Cite